 | • レポートコード：MRC2211A067 • 出版社/出版日：Transparency Market Research / 2022年8月 • レポート形態：英文、PDF、213ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| トレンスペアレンシーマーケットリサーチ社の当調査レポートでは、世界の尿失禁治療用デバイス市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別（尿道スリング、電気刺激装置、人工尿道括約筋、カテーテル）分析、失禁タイプ別（腹圧性尿失禁、切迫性尿失禁、混合失禁、溢流性失禁）分析、エンドユーザー別（病院、外来手術センター、クリニック、家庭）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの内容を掲載しています。なお、当書には、C. R. Bard, Inc. (Becton, Dickinson and Company)、Coloplast Group、Promedon Group、A.M.I. GmbH、Ethicon US, LLC. (Johnson & Johnson)、ZSI Surgical Implants S.R.L.、Medtronic plc、InControl Medical LLC、Hollister Incorporated、Atlantic Therapeutics Group Ltd.などの企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の尿失禁治療用デバイス市場規模：製品別 - 尿道スリングの市場規模 - 電気刺激装置の市場規模 - 人工尿道括約筋の市場規模 - カテーテルの市場規模 ・世界の尿失禁治療用デバイス市場規模：失禁タイプ別 - 腹圧性尿失禁における市場規模 - 切迫性尿失禁における市場規模 - 混合失禁における市場規模 - 溢流性失禁における市場規模 ・世界の尿失禁治療用デバイス市場規模：エンドユーザー別 - 病院における市場規模 - 外来手術センターにおける市場規模 - クリニックにおける市場規模 - 家庭における市場規模 ・世界の尿失禁治療用デバイス市場規模：地域別 - 北米の尿失禁治療用デバイス市場規模 - ヨーロッパの尿失禁治療用デバイス市場規模 - アジア太平洋の尿失禁治療用デバイス市場規模 - 中南米の尿失禁治療用デバイス市場規模 - 中東・アフリカの尿失禁治療用デバイス市場規模 ・競争状況 |
Urinary IncontinenceTreatment Devices Market – Scope of Report
TMR’s report on the global urinary incontinence treatment devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global urinary incontinence treatment devices market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global urinary incontinence treatment devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the urinary incontinence treatment devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global urinary incontinence treatment devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global urinary incontinence treatment devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global urinary incontinence treatment devices market.
The report delves into the competitive landscape of the global urinary incontinence treatment devices market. Key players operating in the global urinary incontinence treatment devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global urinary incontinence treatment devices market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market urinary incontinence treatment devices.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Urinary Incontinence Treatment Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Prevalence of Urinary Incontinence, by Key Region
5.3. Regulatory & Reimbursement Scenario, by Country/Region
5.4. COVID-19 Impact Analysis
6. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Urethral Slings
6.3.1.1. Female Slings
6.3.1.2. Male Slings
6.3.2. Electrical Stimulation Devices
6.3.2.1. Implantable
6.3.2.2. Non-implantable
6.3.3. Artificial Urinary Sphincters
6.3.4. Catheters
6.4. Market Attractiveness Analysis, by Product
7. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Incontinence Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Incontinence Type, 2017–2031
7.3.1. Stress Urinary Incontinence
7.3.2. Urge Urinary Incontinence
7.3.3. Mixed Incontinence
7.3.4. Overflow Incontinence
7.4. Market Attractiveness Analysis, by Incontinence Type
8. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgery Centers
8.3.3. Clinics
8.3.4. Home Use
8.4. Market Attractiveness Analysis, by End-user
9. Global Urinary Incontinence Treatment Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Urinary Incontinence Treatment Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Urethral Slings
10.2.1.1. Female Slings
10.2.1.2. Male Slings
10.2.2. Electrical Stimulation Devices
10.2.2.1. Implantable
10.2.2.2. Non-implantable
10.2.3. Artificial Urinary Sphincters
10.2.4. Catheters
10.3. Market Value Forecast, by Incontinence Type, 2017–2031
10.3.1. Stress Urinary Incontinence
10.3.2. Urge Urinary Incontinence
10.3.3. Mixed Incontinence
10.3.4. Overflow Incontinence
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgery Centers
10.4.3. Clinics
10.4.4. Home Use
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Incontinence Type
10.6.3. By End-user
10.6.4. By Country
11. Europe Urinary Incontinence Treatment Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Urethral Slings
11.2.1.1. Female Slings
11.2.1.2. Male Slings
11.2.2. Electrical Stimulation Devices
11.2.2.1. Implantable
11.2.2.2. Non-implantable
11.2.3. Artificial Urinary Sphincters
11.2.4. Catheters
11.3. Market Value Forecast, by Incontinence Type, 2017–2031
11.3.1. Stress Urinary Incontinence
11.3.2. Urge Urinary Incontinence
11.3.3. Mixed Incontinence
11.3.4. Overflow Incontinence
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgery Centers
11.4.3. Clinics
11.4.4. Home Use
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Incontinence Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Urinary Incontinence Treatment Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Urethral Slings
12.2.1.1. Female Slings
12.2.1.2. Male Slings
12.2.2. Electrical Stimulation Devices
12.2.2.1. Implantable
12.2.2.2. Non-implantable
12.2.3. Artificial Urinary Sphincters
12.2.4. Catheters
12.3. Market Value Forecast, by Incontinence Type, 2017–2031
12.3.1. Stress Urinary Incontinence
12.3.2. Urge Urinary Incontinence
12.3.3. Mixed Incontinence
12.3.4. Overflow Incontinence
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgery Centers
12.4.3. Clinics
12.4.4. Home Use
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Incontinence Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Urinary Incontinence Treatment Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Urethral Slings
13.2.1.1. Female Slings
13.2.1.2. Male Slings
13.2.2. Electrical Stimulation Devices
13.2.2.1. Implantable
13.2.2.2. Non-implantable
13.2.3. Artificial Urinary Sphincters
13.2.4. Catheters
13.3. Market Value Forecast, by Incontinence Type, 2017–2031
13.3.1. Stress Urinary Incontinence
13.3.2. Urge Urinary Incontinence
13.3.3. Mixed Incontinence
13.3.4. Overflow Incontinence
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgery Centers
13.4.3. Clinics
13.4.4. Home Use
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Incontinence Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Urinary Incontinence Treatment Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Urethral Slings
14.2.1.1. Female Slings
14.2.1.2. Male Slings
14.2.2. Electrical Stimulation Devices
14.2.2.1. Implantable
14.2.2.2. Non-implantable
14.2.3. Artificial Urinary Sphincters
14.2.4. Catheters
14.3. Market Value Forecast, by Incontinence Type, 2017–2031
14.3.1. Stress Urinary Incontinence
14.3.2. Urge Urinary Incontinence
14.3.3. Mixed Incontinence
14.3.4. Overflow Incontinence
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgery Centers
14.4.3. Clinics
14.4.4. Home Use
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Incontinence Type
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. C. R. Bard, Inc. (Becton, Dickinson and Company)
15.3.1.1. Company Description
15.3.1.2. Business Overview
15.3.1.3. Financial Overview
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
15.3.2. Coloplast Group
15.3.2.1. Company Description
15.3.2.2. Business Overview
15.3.2.3. Financial Overview
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
15.3.3. Promedon Group
15.3.3.1. Company Description
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. A.M.I. GmbH
15.3.4.1. Company Description
15.3.4.2. Business Overview
15.3.4.3. Financial Overview
15.3.4.4. Strategic Overview
15.3.4.5. SWOT Analysis
15.3.5. Ethicon US, LLC. (Johnson & Johnson)
15.3.5.1. Company Description
15.3.5.2. Business Overview
15.3.5.3. Financial Overview
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. ZSI Surgical Implants S.R.L.
15.3.6.1. Company Description
15.3.6.2. Business Overview
15.3.6.3. Financial Overview
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. Medtronic plc
15.3.7.1. Company Description
15.3.7.2. Business Overview
15.3.7.3. Financial Overview
15.3.7.4. Strategic Overview
15.3.7.5. SWOT Analysis
15.3.8. InControl Medical LLC
15.3.8.1. Company Description
15.3.8.2. Business Overview
15.3.8.3. Financial Overview
15.3.8.4. Strategic Overview
15.3.8.5. SWOT Analysis
15.3.9. Hollister Incorporated
15.3.9.1. Company Description
15.3.9.2. Business Overview
15.3.9.3. Financial Overview
15.3.9.4. Strategic Overview
15.3.9.5. SWOT Analysis
15.3.10. Atlantic Therapeutics Group Ltd.
15.3.10.1. Company Description
15.3.10.2. Business Overview
15.3.10.3. Financial Overview
15.3.10.4. Strategic Overview
15.3.10.5. SWOT Analysis
15.3.11. B. Braun Melsungen AG
15.3.11.1. Company Description
15.3.11.2. Business Overview
15.3.11.3. Financial Overview
15.3.11.4. Strategic Overview
15.3.11.5. SWOT Analysis
15.3.12. Teleflex Incorporated
15.3.12.1. Company Description
15.3.12.2. Business Overview
15.3.12.3. Financial Overview
15.3.12.4. Strategic Overview
15.3.12.5. SWOT Analysis
Table 01: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031
Table 03: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 04: Global Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031
Table 08: North America Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 11: Europe Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031
Table 12: Europe Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Asia Pacific Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031
Table 16: Asia Pacific Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Latin America Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031
Table 20: Latin America Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Middle East & Africa Urinary Incontinence Treatment Devices Market Value (US$ Mn) Forecast, by Incontinence Type, 2017–2031
Table 24: Middle East & Africa Urinary Incontinence Treatment Devices Market (US$ Mn) Forecast, by End-user, 2017–2031